» Articles » PMID: 11704930

A Missense Mutation in a Highly Conserved Region of CASQ2 is Associated with Autosomal Recessive Catecholamine-induced Polymorphic Ventricular Tachycardia in Bedouin Families from Israel

Overview
Journal Am J Hum Genet
Publisher Cell Press
Specialty Genetics
Date 2001 Nov 13
PMID 11704930
Citations 204
Authors
Affiliations
Soon will be listed here.
Abstract

Catecholamine-induced polymorphic ventricular tachycardia (PVT) is characterized by episodes of syncope, seizures, or sudden death, in response to physical activity or emotional stress. Two modes of inheritance have been described: autosomal dominant and autosomal recessive. Mutations in the ryanodine receptor 2 gene (RYR2), which encodes a cardiac sarcoplasmic reticulum (SR) Ca(2+)-release channel, were recently shown to cause the autosomal dominant form of the disease. In the present report, we describe a missense mutation in a highly conserved region of the calsequestrin 2 gene (CASQ2) as the potential cause of the autosomal recessive form. The CASQ2 protein serves as the major Ca(2+) reservoir within the SR of cardiac myocytes and is part of a protein complex that contains the ryanodine receptor. The mutation, which is in full segregation in seven Bedouin families affected by the disorder, converts a negatively charged aspartic acid into a positively charged histidine, in a highly negatively charged domain, and is likely to exert its deleterious effect by disrupting Ca(2+) binding.

Citing Articles

Next generation sequencing: a possible answer to sudden unexplained deaths in a young South African cohort?.

van Deventer B, du Toit-Prinsloo L, van Niekerk C Forensic Sci Med Pathol. 2025; .

PMID: 39900885 DOI: 10.1007/s12024-025-00944-6.


The Role of Human-Induced Pluripotent Stem Cells in Studying Cardiac Channelopathies.

Begovic M, Schneider L, Zhou X, Hamdani N, Akin I, El-Battrawy I Int J Mol Sci. 2024; 25(22).

PMID: 39596103 PMC: 11593457. DOI: 10.3390/ijms252212034.


Sudden Cardiac Death and Channelopathies: What Lies behind the Clinical Significance of Rare Splice-Site Alterations in the Genes Involved?.

Pesaresi M, Bernini Di Michele A, Melchionda F, Onofri V, Alessandrini F, Turchi C Genes (Basel). 2024; 15(10).

PMID: 39457396 PMC: 11507433. DOI: 10.3390/genes15101272.


Sudden death in epilepsy: the overlap between cardiac and neurological factors.

Shlobin N, Thijs R, Benditt D, Zeppenfeld K, Sander J Brain Commun. 2024; 6(5):fcae309.

PMID: 39355001 PMC: 11443455. DOI: 10.1093/braincomms/fcae309.


Identifying the Pathogenic Variants in Heart Genes in Vietnamese Sudden Unexplained Death Victims by Next-Generation Sequencing.

Nguyen Tat T, Lien N, Luu Sy H, Ta Van T, Dang Viet D, Nguyen Thi H Diagnostics (Basel). 2024; 14(17).

PMID: 39272661 PMC: 11394071. DOI: 10.3390/diagnostics14171876.


References
1.
Swan H, Piippo K, Viitasalo M, Heikkila P, Paavonen T, Kainulainen K . Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts. J Am Coll Cardiol. 1999; 34(7):2035-42. DOI: 10.1016/s0735-1097(99)00461-1. View

2.
Viskin S, Belhassen B . Polymorphic ventricular tachyarrhythmias in the absence of organic heart disease: classification, differential diagnosis, and implications for therapy. Prog Cardiovasc Dis. 1998; 41(1):17-34. DOI: 10.1016/s0033-0620(98)80020-0. View

3.
Volders P, Vos M, Szabo B, Sipido K, de Groot S, Gorgels A . Progress in the understanding of cardiac early afterdepolarizations and torsades de pointes: time to revise current concepts. Cardiovasc Res. 2000; 46(3):376-92. DOI: 10.1016/s0008-6363(00)00022-5. View

4.
Stokes D, Wagenknecht T . Calcium transport across the sarcoplasmic reticulum: structure and function of Ca2+-ATPase and the ryanodine receptor. Eur J Biochem. 2000; 267(17):5274-9. DOI: 10.1046/j.1432-1327.2000.01569.x. View

5.
Tiso N, Stephan D, Nava A, Bagattin A, Devaney J, Stanchi F . Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet. 2001; 10(3):189-94. DOI: 10.1093/hmg/10.3.189. View